20195 ⎘
Medicinal preparations containing organic active ingredients Nitro compounds
ACETYL-COA CARBOXYLASE MODULATORS
#2COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS
#3METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#4ORGANIC COMPOUND (OXIME) TO COMBAT CHEMICAL WARFARE AGENTS
#5COSMETIC AND NON-COSMETIC COMPOSITIONS AND METHODS OF USE
#6COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#7TOPICAL CONTACT SENSITIZERS TO TREAT CANCER
#8METHODS AND MATERIALS FOR TREATING HEART ATTACK
#9METHODS OF TREATING RETT SYNDROME USING FENFLURAMINE
#10NITRIC OXIDE FORMULATION DELIVERY DEVICE AND METHOD OF USE
#11PROTEIN HYDROLYSATES
#12COMPRESSED TABLETS
#13COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING COMPOUNDS FOR TREATING CHOROIDAL VASCULAR DISEASES AND METHODS OF THEIR USE
#14ENAMINE N-OXIDES: SYNTHESIS AND APPLICATION TO HYPOXIA-RESPONSIVE PRODRUGS AND IMAGING AGENTS
#15COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#16Nitric Oxide Delivery Device for Healing Skin Wounds
#17Method for supporting memory function and/or cognitive function
#18TARGETING CHROMOSOMAL INSTABILITY AND DOWNSTREAM CYTOSOLIC DNA SIGNALING FOR CANCER TREATMENT
#19COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#20METHODS AND COMPOSITIONS FOR CONSISTENT INTRACORONARY ADMINISTRATION OF A BIOLOGIC
#21COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#22COMPOSITIONS FOR REDUCTION OF OXIDATIVE STRESS, IMPROVEMENT TO THE IMMUNE SYSTEM, PROMOTION OF HEALTHY CARTILAGE AND/OR ALLEVIATION OF PAIN ACCOMPANYING INFLAMMATORY DISEASES IN RUMINANTS
#23METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS
#24NOVEL USES
#25NON-THERAPEUTIC METHODS FOR ALLEVIATING OR REDUCING STRESS SYMPTOMS OF RUMINANTS
#26COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#27COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#28COMPOUNDS FOR USE IN THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA
#29PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY
#30L-SEPIAPTERIN AND METHODS OF USE FOR TREATING DISEASES AND DISORDERS
#31Combination therapy for cancer treatment
#32METHOD TO PREVENT AND TREAT MACULAR DEGENERATION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#33PHARMACEUTICAL COMPOSITION COMPRISING TRANS - CINNAMALDEHYDE AND ITS USE IN THE TREATMENT OF INFECTIONS
#34Treatments of cancer using nitrous oxide and botulinum toxin
#35ANTI-CANCER COMPOUNDS ACTING AS NON-PGP SUBSTRATE
#36Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
#37TREATMENT OF A RESPIRATORY CORONAVIRUS INFECTION WITH NITROXIDES
#38PROTEIN HYDROLYSATES
#39PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY
#40COMPOSITIONS AND METHODS FOR PROMOTING HEALTHY NEURAL DEVELOPMENT IN AN UNBORN BABY
#41COMPOSITIONS AND METHODS OF MODULATING CASOTRANSMITTER SIGNALING
#42Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose
#43Compositions and methods for in vivo lung and blood SNO repletion
#44Inorganic nitrite to improve cardiopulmonary hemodynamics
#45PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION
#46METHOD OF TREATING POSTPRANDIAL INFLAMMATION AND PREVENTING WEIGHT GAIN
#47DELIVERY OF HIGH CONCENTRATION NITRIC OXIDE
#48Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5)
#49Method for supporting memory function and/or cognitive function
#50SOS1 ALLOSTERIC SITE TARGETING
#51METHOD TO PREVENT AND TREAT GINGIVAL RECESSION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#52METHOD TO PREVENT AND TREAT HEARING LOSS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#53METHOD OF PREVENTING OR TREATING SIDE EFFECT OF TUMOR THERAPY
#54Pharmaceutical composition
#55METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#56Method to prevent and treat macular degeneration by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
#5717beta-heterocyclyl-digitalis like compounds for the treatment of heart failure
#58ACETYL-COA CARBOXYLASE MODULATORS
#59Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine Asignaling and/or adenosine Areceptor expression
#60TRANSDERMAL DRUG DELIVERY METHOD AND SYSTEM
#61Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
#62Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment
#63METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB
#64METHODS FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS CAUSED BY ISCHEMIA USING CONTACT VASODILATORS
#65Vaginal systemic drug delivery
#66TOPICAL COMPOSITION
#67Two-part nitric oxide generating topical compositions
#68Antiviral agents for drug-resistant influenza A
#69Methods and compositions for treating neurological conditions
#70Methods for the non-therapeutic alleviation or prophylaxis of symptoms of oxidative stress, reduced immune system or cartilage damage of ruminants
#71Non-therapeutic methods for alleviating or reducing stress symptoms of ruminants
#72Biosynchronous transdermal drug delivery
#73Combination Therapy for Cancer Treatment
#74Method of preventing or treating side effect of tumor therapy
#75Use Of Inhaled Nitric Oxide For The Treatment Of Pulmonary Hypertension Associated With Lung Disease
#76Compressed tablets
#77COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#78Pharmaceutical composition
#79Storage-stable formulations
#80ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
#81Compositions and methods for targeting cancers
#82INDUCTION OF ARTERIOGENESIS
#83Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases
#84Methods of administering inhaled nitric oxide gas
#85COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#86PROTEIN HYDROLYSATES
#87Cannabinergic nitrate esters and related analogs
#88Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
#89Modulators of ATP-binding cassette transporters
#90Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#91Acetyl-CoA carboxylase modulators
#92Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
#93METHOD FOR TREATING BRAIN ATROPHY
#94Method for supporting memory function and/or cognitive function
#95Medicated propolis oil composition
#96Antiviral agents for amantadine-resistant influenza A
#97Inorganic nitrite to improve cardiopulmonary hemodynamics
#98VALPROIC ACID FOR TREATMENT OF MYOCARDIAL ISCHEMIA
#99SOLID DRUG DISPENSING APPARATUS, FORMULATIONS, AND METHODS OF USE
#100Intralesional (Intratumoral) dinitrochlorobenzene and associated compounds coadministered with checkpoint inhibitors for cancer treatment including treatment of metastatic cutaneous cancers
#101Use of alpha-hydroxy carbonyl compounds as reducing agents
#102Combination therapy for cancer treatment
#103PRODUCTION OF NITRO-FATTY ACIDS AND NITRO-HYDROCARBONS BY AMMONIA OXIDIZING BACTERIA
#104Compositions for topical treatment of microbial infections
#105INTRAVENOUS ACCESS DEVICE
#106Methods and use of compounds that bind to RelA of NF-kB
#107Methods for inhibiting conversion of choline to trimethylamine (TMA)
#108Methods for treating hypersomnolence
#109Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
#110Compositions and methods for treating ocular diseases
#111METHOD FOR ENHANCED UPTAKE OF VIRAL VECTORS IN THE MYOCARDIUM
#112Methods and compositions for consistent intracoronary administration of a biologic
#113Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#114COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS
#115Cannabinergic nitrate esters and related analogs
#116Compounds and methods for inhibiting production of trimethylamine
#117Transdermal drug delivery method and system
#118Combination therapy for cancer treatment
#119Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
#120Method for treatment of radiologically-dense breasts
#121Anti-microbial composition
#122INDUCTION OF ARTERIOGENESIS
#123MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#124Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
#125Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
#126METHOD FOR ENHANCED UPTAKE OF VIRAL VECTORS IN THE MYOCARDIUM
#127Treatment of inflammatory skin disease
#128Drinking water formulation and method and article relating to same
#129Compositions for topical treatment of microbial infections
#130Acetyl CoA carboxylase modulators
#131NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION
#132USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES
#133Cannabinergic nitrate esters and related analogs
#134Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
#135Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
#136Biosynchronous transdermal drug delivery
#137Transdermal drug delivery method and system
#138Performance-Enhancing Nasal Irrigation
#139Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
#140Java ginger extract and manufacturing method
#141“Micro-patch” for assessment of the local microvasculature and microcirculatory vasoreactivity
#142Method of treating . infection
#143Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#144Isoamyl nitrite formulations
#145Activity modulator, medicinal agent comprising same, use of CD300A gene-deficient mouse, and anti-CD300A antibody
#146Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#147METHODS OF DISTRIBUTING A PHARMACEUTICAL PRODUCT COMPRISING NITRIC OXIDE GAS FOR INHALATION
#148Modulators of ATP-binding cassette transporters
#149Biaryl heterocycle substituted oxazolidinone antibacterial agents
#150METHOD FOR ENHANCED UPTAKE OF VIRAL VECTORS IN THE MYOCARDIUM
#151Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance
#152Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
#153Induction of Arteriogenesis
#154Compositions and methods for targeting of treating neoplasms
#155Anti-microbial composition
#156Compositions for topical treatment of microbial infections
#157Medicament for LCT poisoning
#158COMPOSITIONS AND METHODS OF INHIBITING RETINAL DEGENERATION
#159SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS
#160Method for enhanced uptake of viral vectors in the myocardium
#161Anti-viral formulations
#162Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production
#163Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas
#164USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS
#165Modulators of ATP-binding cassette transporters
#166Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#167Drinking water formulation and method and article relating to same
#168SMALL MOLECULE MODIFIERS OF MICRORNA MIR-122
#169Diagnostic Methods for Assessing Risk of Chagas Disease and Heart Failure
#170Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#171SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION
#172MODULATING LYMPHATIC FUNCTION
#173NOVEL MEDICAL USES FOR NO AND NO DONOR COMPOUNDS
#174Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#175Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating Thereto
#176Etoposide and doxorubicin conjugates for drug delivery
#177Skin treatment compositions
#178EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN
#179Therapeutic Inhibitor of Vascular Smooth Muscle Cells
#180SMALL-MOLECULE INHIBITORS OF PROTEIN SYNTHESIS INACTIVATING TOXINS
#181Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
#182ALTERNATE MORPHEEINS OF ALLOSTERIC PROTEINS AS A TARGET FOR THE DEVELOPMENT OF BIOACTIVE MOLECULES
#183METHOD TO MODULATE HEMATOPOIETIC STEM CELL GROWTH
#184Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide
#185Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions
#186METHODS OF USE OF ANTIVIRAL COMPOUNDS
#187Use of capsiate or dihydrocapsidate
#188METHOD FOR TREATING WOUNDS BY ADMINISTERING FULLERENES
#189TREATING PATIENTS WITH SUBARACHNOID HEMORRHAGE
#190Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide
#191Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide
#192METHODS OF TREATING TERM AND NEAR-TERM NEONATES HAVING HYPOXIC RESPIRATORY FAILURE ASSOCIATED WITH CLINICAL OR ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION
#193METHODS OF TREATING TERM AND NEAR-TERM NEONATES HAVING HYPOXIC RESPIRATORY FAILURE ASSOCIATED WITH CLINICAL OR ECHOCARDIOGRAPHIC EVIDENCE OF PULMONARY HYPERTENSION
#194BEVERAGE COMPRISING ARGININE
#195Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
#196BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY
#197Methods and compositions for facilitating arterial access
#198Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
#199Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
#200LONG-TERM STABLE PHARMACEUTICAL PREPARATION CONTAINING THE ACTIVE INGREDIENT GLYCEROL TRINITRATE
#201AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR
#202Pharmaceutical composition
#203Compositions and methods for the inhibition of endothelial nitric oxide synthase activity
#204SOLUBLE GUANYLATE CYCLASE (SGC) MODULATORS FOR TREATMENT OF LIPID RELATED DISORDERS
#205Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics
#206Compositions And Method For The Treatment Of Acne
#207Targeting cancer therapy combination
#208Use of alpha-hydroxy carbonyl compounds as reducing agents
#209Delivery of high concentration nitric oxide
#210Use of a Blood-Flow Decrease Preventing Agent in Conjunction With Insufflating Gas
#211S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions
#212Agonists of a bitter taste receptor and uses thereof
#213NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION
#214COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER
#215USE OF ARCHAEA TO MODULATE THE NUTRIENT HARVESTING FUNCTIONS OF THE GASTROINTESTINAL MICROBIOTA
#216Use of triacontanol in preparation of medicaments for treatment of cancers
#217Methods for diagnosing and treating a heart condition in a patient
#218Chemically defined vaccine stabiliser
#219STABLE WATER-BASED TOPICAL PHARMACEUTICAL CREAMS AND METHODS OF MAKING AND USING SAME
#220Inhibitors of Egln3 Activity for the Treatment of Neurodegenerative Disorders
#221Treatment of nail infections with no
#222TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#223MEDICAMENT FOR LCT POISONING
#224Pharmaceutical composition
#225All Natural Antifungal And Antimicrobial Composition And Method Thereof
#226Modulators of ATP-binding cassette transporters
#227COMPOSITION BENEFICIAL FOR VISUOGNOSIS PERSISTENCE AND USE THEREOF
#228No-modified hemoglobins and uses therefor
#229Method for determining physiological effects of hemoglobin
#230Modulators of ATP-binding cassette transporters
#231Method for enhanced uptake of viral vectors in the myocardium
#232ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS
#233TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS
#234Use of nitroaniline derivatives for the production of nitric oxide
#235Nitrosated and/or nitrosylated compounds, compositions and methods of use
#236Carisoprodol, Phenytoin and Fosphenytoin Articles and Methods
#237Use of nitrooxyderivatives of drug for the treatment of muscular dystrophies
#238COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS
#239Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
#240Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof
#241Nitrosated and Nitrosylated Compounds, Compositions and Methods for the Treatment of Ophthalmic Disorders
#242Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
#243USE OF 4-(NITROOXY)-BUTYL-(S)-2-(6-METHOXY-2-NAPHTHYL)-PROPANOATE FOR TREATING PAIN AND INFLAMMATION
#244Modulating Lymphatic Function
#245Treatment method for MMP-implicated pathologies
#246Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
#247Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
#248Methods, Compositions and Devices For Promoting Anglogenesis
#249“Micro-patch” for assessment of the local microvasculature and microcirculatory vasoreactivity
#250Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof
#251Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
#252Red blood cells loaded with s-nitrosothiol and uses therefor
#253Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#254Methods for the administration of amifostine and related compounds
#255NEUROPROTECTION BY BLOOD FLOW STABILIZATION
#256Fetal physiology during maternal surgery or diagnosis
#257Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
#258ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS
#259Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
#260Prevention of Cell Proliferation by Inhibiting Myosin Light Chain Kinase
#261Modulators of ATP-binding cassette transporters
#262Device for application of medicaments, manufacturing method therefor, and method of treatment
#263Inhibition of angiogenesis through nitric oxide tachyphylaxis
#264Androgen Receptor Modulators
#265Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders
#266COMPOSITION AND METHOD FOR FACILITATING THE HEALING OF NON-HEALING AND SLOW-HEALING WOUNDS AND ULCERATIONS
#267Cholesterol lowering drug combination
#268Pharmaceutical compositions comprising amifostine and related compounds
#269Treating sex steriod responsive disorders
#270Combination Therapy for Vascular Complications Associated with Hyperglycemia
#271NO-modified hemoglobins and uses therefor
#272Treatment for Necrotizing Enterocolitis
#273Methods and Compositions for the Treatment of Cell Proliferation
#274Use of nitric oxide adducts
#275Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
#276Antiviral methods and compositions
#277Compounds that inhibit caspase activity for treating glaucoma
#278Pharmaceutical composition
#279BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY
#280Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction
#281Advanced glycation end-product intermediaries and post-amadori inhibition
#282Therapeutic inhibitor of vascular smooth muscle cells
#283Therapeutic inhibitor of vascular smooth muscle cells
#284Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars)
#285Topical pharmaceutical composition for the treatment of inflammatory dermatoses
#286Methods and compositions for mitigating pain
#287Methods involving aldose reductase inhibitors
#288Methods and compositions involving aldose reductase
#289Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
#290Prevention of flap necrosis in plastic surgery
#291Methods for the administration of amifostine and related compounds
#292Formulation which can be administered gastrointestinally, containing green tea extract and an no donor
#2931-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
#294Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
#295Modulators of ATP-binding cassette transporters
#2961-chloro-2,4-dinitrobenzene gel compositions and methods for using the same
#297Biosynchronous transdermal drug delivery
#298Red blood cells loaded with -nitrosothiol and uses therefor
#299Topical pharmaceutical composition to treat hyperpigmentation of the skin
#300Topical administration of amifostine and related compounds